White matter disease: Optimizing rituximab therapy for neuromyelitis optica

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)664-665
Number of pages2
JournalNature Reviews Neurology
Volume7
Issue number12
DOIs
StatePublished - Dec 2011

Fingerprint

Murine-Derived Monoclonal Antibodies
Neuromyelitis Optica
Leukoencephalopathies
Therapeutics
Rituximab

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

White matter disease : Optimizing rituximab therapy for neuromyelitis optica. / Wingerchuk, Dean Marko; Weinshenker, Brian G.

In: Nature Reviews Neurology, Vol. 7, No. 12, 12.2011, p. 664-665.

Research output: Contribution to journalArticle

@article{1072eb1405274e5b952b1af005393d17,
title = "White matter disease: Optimizing rituximab therapy for neuromyelitis optica",
author = "Wingerchuk, {Dean Marko} and Weinshenker, {Brian G}",
year = "2011",
month = "12",
doi = "10.1038/nrneurol.2011.154",
language = "English (US)",
volume = "7",
pages = "664--665",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - White matter disease

T2 - Optimizing rituximab therapy for neuromyelitis optica

AU - Wingerchuk, Dean Marko

AU - Weinshenker, Brian G

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=83055194270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83055194270&partnerID=8YFLogxK

U2 - 10.1038/nrneurol.2011.154

DO - 10.1038/nrneurol.2011.154

M3 - Article

C2 - 21989243

AN - SCOPUS:83055194270

VL - 7

SP - 664

EP - 665

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 12

ER -